ARVO 2022: Outcomes of Diabetic Eye Disease Treatment Vary Based on Race, Insurance Status
Hispanic and Black patients exhibited worse baseline visual acuity and outcomes posttreatment compared with White patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.